These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7535469)

  • 21. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.
    Callahan BT; Cord BJ; Ricaurte GA
    Synapse; 2001 May; 40(2):113-21. PubMed ID: 11252022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
    Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ
    Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K; Brennan KA; Colussi-Mas J; Schenk S
    Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems.
    Gartside SE; McQuade R; Sharp T
    Neuropharmacology; 1997; 36(11-12):1697-703. PubMed ID: 9517441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nuclei: effect of a neurotoxic amphetamine.
    McQuade R; Sharp T
    Neuroscience; 1995 Oct; 68(4):1079-88. PubMed ID: 8544983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats.
    Laferrere B; Wurtman RJ
    Brain Res; 1989 Dec; 504(2):258-63. PubMed ID: 2480833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine.
    Murray TK; Williams JL; Misra A; Colado MI; Green AR
    Neuropharmacology; 1996; 35(11):1615-20. PubMed ID: 9025109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
    Gough B; Imam SZ; Blough B; Slikker W; Ali SF
    Ann N Y Acad Sci; 2002 Jun; 965():410-20. PubMed ID: 12105116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex.
    Sarkissian CF; Wurtman RJ; Morse AN; Gleason R
    Brain Res; 1990 Oct; 529(1-2):294-301. PubMed ID: 1704283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats.
    Kehne JH; Padich RA; McCloskey TC; Taylor VL; Schmidt CJ
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):95-106. PubMed ID: 8935804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention deficits induced by acute p-chloroamphetamine following fear conditioning in the rat.
    Archer T; Ogren SO; Ross SB; Magnusson O
    Psychopharmacology (Berl); 1984; 82(1-2):14-9. PubMed ID: 6229804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    Schmidt CJ; Black CK; Taylor VL
    Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.
    Poland RE; Lutchmansingh P; McCracken JT; Zhao JP; Brammer GL; Grob CS; Boone KB; Pechnick RN
    Psychopharmacology (Berl); 1997 Jun; 131(4):411-9. PubMed ID: 9226745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.
    Hatzidimitriou G; Tsai EH; McCann UD; Ricaurte GA
    Synapse; 2002 Apr; 44(1):51-7. PubMed ID: 11842446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
    Zolkowska D; Rothman RB; Baumann MH
    J Pharmacol Exp Ther; 2006 Aug; 318(2):604-10. PubMed ID: 16644904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
    Gu XF; Azmitia EC
    Eur J Pharmacol; 1993 Apr; 235(1):51-7. PubMed ID: 8100196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.